Benchling for Hybridoma Technology
Oct 20, 2021
Hybridoma technology is a well-established method for generating monoclonal antibodies (mAB), but various scientific and organizational challenges persist. Laborious and resource-intensive processes, low titers, and complex assays mean that scientists have to streamline every step, simplify handoffs, and track large amounts of complex data. Robust data management is key to effectively leveraging this antibody technology. This application note discusses how Benchling’s capabilities can power hybridoma technology and help scientists manage the entire process from antigen design to antibody characterization.
Benchling for Hybridoma Technology.pdf
- Zebrafish Tumor Graft Transplantation to Grow Tumors In Vivo That Engraft Poorly as Single Cell Suspensions
- An Automated Low-Cost Swim Tunnel for Measuring Swimming Performance in Fish
- A Rabbit Femoral Condyle Defect Model for Assessment of Osteochondral Tissue Regeneration
- Cartilage Assessment Requires a Surface Characterization Protocol: Roughness, Friction, and Function